Cosmetic manufacturing facilities registered with the FDA under the Modernization of Cosmetics Regulation Act (MoCRA) face their first biennial renewal cycle, with submissions due between October 1 and December 31, 2025.

The renewal requirement comes directly from MoCRA, which took effect in December 2022 and gave the industry its first federal registration mandate for cosmetic facilities. Under the law, every facility that manufactures or processes cosmetic products for US distribution must register with the FDA and renew that registration every two years during the renewal window. Facilities that obtained or updated their registration during the initial implementation period in 2023-2024 now face the first renewal deadline.

For quality and regulatory teams, the practical implications are immediate. A facility that fails to renew within the window loses its active registration status, which jeopardizes its ability to legally introduce cosmetic products into US commerce. MoCRA also ties registration status to product listing obligations: brand owners must list each marketed cosmetic product with the FDA, and updates to those listings follow a similar two-year cycle for updates, with the same October-December renewal window applying to listing refreshes.

The workload question is real. Companies operating multiple sites — contract manufacturers with several US plants, or brands using a network of third-party fillers — must verify that each facility's registration information is current before submission. The renewal submission requires confirming the facility's legal name, address, ULID (Unique Establishment Identifier), and the categories of products manufactured there. Any structural changes since the initial registration — new ownership, relocated production lines, added product categories — must be reflected in the renewal, not patched in later.

Procurement and supply-chain teams should treat this as a vendor-qualification checkpoint. Brands sourcing from contract manufacturers will want confirmation that their manufacturing partners have renewed on time, because a lapsed facility registration upstream can disrupt a brand's own compliance posture and product listings tied to that facility.

The mechanics run through the FDA's Cosmetics Direct portal, the same system used for initial registrations and product listings. Companies that submitted through the portal can renew electronically, and the FDA has encouraged early filing within the three-month window rather than waiting for the December 31 cutoff. System congestion near deadlines has been a recurring issue since the portal launched, and late-year filing surges carry operational risk that a simple October submission avoids.

There is also a small-business dimension. MoCRA exempted certain small businesses from registration requirements in specific circumstances, but the exemptions are narrow and fact-specific. Companies relying on an exemption should re-confirm eligibility each cycle rather than assuming it carries forward automatically, particularly if annual sales, product mix, or facility arrangements have changed.

For international manufacturers exporting to the United States, the same rule applies: foreign facilities that manufacture cosmetics for US distribution must hold an active FDA registration, and the renewal cycle applies equally to them. US importers should verify that their overseas suppliers are aware of the October-December window, since enforcement attention at the border tends to follow registration lapses.

The first data point to watch after this cycle: whether the FDA publishes updated guidance or enforcement posture in early 2026 regarding facilities that missed the window, and whether the agency's registration database shows a measurable drop in active facilities — a signal of both compliance gaps and consolidation in contract manufacturing.